References
- Cintra VP, Lourenço CM, Marques SE, de Oliveira LM, Tumas V, Marques W. Mutational screening of 320 Brazilian patients with autosomal dominant spinocerebellar ataxia. J Neurol Sci 2014;347:375–9. doi:10.1016/j.jns.2014.10.036 doi: 10.1016/j.jns.2014.10.036
- Teive HAG, Ashizawa T. Primary and secondary ataxias. Curr Opin Neurol 2015;28:413–22. doi:10.1097/WCO.0000000000000227 doi: 10.1097/WCO.0000000000000227
- Moro A, Munhoz RP, Moscovich M, Arruda WO, Raskin S, Teive HAG. Movement disorders in Spinocerebellar ataxias in a cohort of Brazilian patients. Arq Neuropsiquiatr 2014;72:659–62. doi:10.1159/000365285 doi: 10.1590/0004-282X20140129
- Teive HAG, Munhoz RP, Arruda WO, Lopes-Cendes I, Raskin S, Werneck LC, et al. Spinocerebellar ataxias – genotype-phenotype correlations in 104 Brazilian families. Clinics 2012;67:443–9. doi:10.6061/clinics/2012(05)07 doi: 10.6061/clinics/2012(05)07
- Abdulmassih EMS, Teive HAG, Santos RS. The evaluation of swallowing in patients with spinocerebellar ataxia and oropharyngeal dysphagia: a comparison study of videofluoroscopic and sonar Doppler. Int Arch Otorhinolaryngol 2013;17:66–73. doi:10.7162/S1809-97772013000100012.
- Bushart DD, Murphy GG, Shakkottai VG. Precision medicine in spinocerebellar ataxias : treatment based on common mechanisms of disease. Ann Transl Med 2016;4:1–14. doi:10.3978/j.issn.2305-5839.2016.01.06.
- Mari S, Serrao M, Casali C, Conte C, Martino G, Ranavolo A, et al. Lower limb antagonist muscle co-activation and its relationship with gait parameters in cerebellar ataxia. Cerebellum 2014;13:226–36. doi:10.1007/s12311-013-0533-4 doi: 10.1007/s12311-013-0533-4
- Teive HAG. Spinocerebellar ataxias. Arq Neuropsiquiatr 2009;67:1133–42. doi: 10.1590/S0004-282X2009000600035
- Teive HAG, Moro A, Moscovich M, Arruda WO, Munhoz RP, Raskin S, et al. Spinocerebellar ataxia type 10 in the South of Brazil: the Amerindian-Belgian connection. Arq Neuropsiquiatr 2015;73:725–7. doi:10.1590/0004-282X20150086 doi: 10.1590/0004-282X20150086
- Beavers KM, Beavers DP, Houston DK, Harris TB, Hue TF, Koster A, et al. Associations between body composition and gait-speed decline: results from the health, aging, and body composition study. Am J Clin Nutr 2013;97:552–60. doi:10.3945/ajcn.112.047860 doi: 10.3945/ajcn.112.047860
- De Lorenzo A, Bianchi A, Maroni P, Iannarelli A, Di Daniele N, Iacopino L, et al. Adiposity rather than BMI determines metabolic risk. Inter J Cardiol 2013;166:111–7. doi: 10.1016/j.ijcard.2011.10.006
- Barbosa-Silva MCG, Barros AJ, Wang J. Bioelectrical impedance analysis: population reference values for phase angle by age and sex. Am J Clin Nutr 2005;82:49–52. doi: 10.1093/ajcn/82.1.49
- Dehghan M, Merchant AT. Is bioelectrical impedance accurate for use in large epidemiological studies? Nutr J 2008;7:330. doi:10.1186/1475-2891-7-26 doi: 10.1186/1475-2891-7-26
- Weyer MA, Schmitz-Hubsch T, Schoch B, Frings M, Timmann D, Klockgether T. Reliability and validity of the scale for the assessment and rating of ataxia: a study in 64 ataxia patients. Mov Disord 2007;22:1633–7. doi:10.1002/mds.21544 doi: 10.1002/mds.21544
- Lohmann TG. Anthropometry and body composition. Anthropometric standardization reference manual. Champaign (IL): Human Kinetics; 1988.
- World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization; 2000.
- Kyle UG, Bosaeus I, De Lorenzo A, Deurenberg P, Elia M, Gómez JM, et al. Bioelectrical impedance analysis -part II: utilization in clinical practice. Clin Nutr 2004;23:1430–53. doi:10.1016/j.clnu.2004.09.012 doi: 10.1016/j.clnu.2004.09.012
- Kyle UG, Genton L, Karsegard L, Slosman D, Pichard C. Single prediction equation for bioelectrical impedance analysis in adults aged 20–94 years. Nutrition 2001;17:248–53. doi:10.3109/03091902.2010.543751 doi: 10.1016/S0899-9007(00)00553-0
- Kotnik KZ, Robič T, Golja P. Which method to use for a fast assessment of body fat percentage? Physiol Meas 2015;36:1453–68. doi:10.1088/0967-3334/36/7/1453 doi: 10.1088/0967-3334/36/7/1453
- Baumgartner RN, Chumlea WC, Roche AF. Bioelectric impedance phase angle and body composition. Am J Clin Nutr 1988;48(1):16–23. doi: 10.1093/ajcn/48.1.16
- Hamilton JM, Wolfson T, Peavy GM, Jacobson MW, Corey-Bloom J. Rate and correlates of weight change in Huntington’s disease. J Neurol Neurosurg Psychiatry 2004;75:209–12. doi:10.1136/jnnp.2003.017822 doi: 10.1136/jnnp.2003.017822
- Pruna L, Chatelin J, Pascal-Vigneron V, Kaminsky P. Regional body composition and functional impairment in patients with myotonic dystrophy. Muscle Nerve 2011;44:503–8. doi:10.1002/mus.22099 doi: 10.1002/mus.22099
- Durrieu G, Lau MEL, Rascol O, Senard JM, Rascol A, Montastruc JL. Parkinson’s disease and weight loss: a study with anthropometric and nutritional assessment. Clin Auton Res 1992;2:153–7. doi: 10.1007/BF01818955
- Fernández MC, Parisi MS, Díaz SP, Mastaglia SR, Deferrari JM, Seijo M, et al. A pilot study on the impact of body composition on bone and mineral metabolism in Parkinson’s disease. Parkinsonism Relat Disord 2007;13:355–8. doi:10.1016/j.parkreldis.2006.12.010 doi: 10.1016/j.parkreldis.2006.12.010
- Petroni ML, Albani G, Bicchiega V, Baudo S, Vinci C, Montesano A, et al. Body composition in advanced-stage Parkinson’s disease. Acta Diabetol 2003;40:187–90. doi:10.1007/s00592-003-0062-6 doi: 10.1007/s00592-003-0062-6
- Kashihara K. Weight loss in Parkinson’s disease. J Neurol 2006;253:38–41. doi:10.1007/s00592-003-0062-6 doi: 10.1007/s00415-005-0917-6
- Djoussé L, Knowlton B, Cupples LA, Marder K, Shoulson I, Myers RH. Weight loss in early stage of Huntington’s disease. Neurology 2002;59:1325–30. doi: 10.1212/01.WNL.0000031791.10922.CF
- Aziz NA, van der Marck MA, Pijl H, Olde Rikkert MGM, Bloem BR, Roos RAC. Weight loss in neurodegenerative disorders. J Neurol 2008;255:1872–80. doi:10.1007/s00415-009-0062-8 doi: 10.1007/s00415-009-0062-8
- Saute JAM, Chaves A, Souza GN, Russo AD, Donis HC, Vedolin E, et al. Body mass index is inversely correlated with the expanded CAGrepeat length in SCA3/MJD patients. Cerebellum 2011;11:771–4. doi:10.1007/s12311-011-0326-6 doi: 10.1007/s12311-011-0326-6
- Finkelstein JS, Lee H, Burnett-Bowie SAM, Pallais JC, Yu EW, Borges LF, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 2013;369:1011–22. doi:10.1056/NEJMoa1206168 doi: 10.1056/NEJMoa1206168
- Escobar-Morreale HF, Alvarez-Blasco F, Botella-Carretero JI, Luque-Ramírez M. The striking similarities in the metabolic associations of female androgen excess and male androgen deficiency. Hum Reprod 2014:1–9. doi:10.1093/humrep/deu198.
- Ragnarsson O, Burt MG, Ho KKY, Johannsson G. Effect of short-term GH and testosterone administration on body composition and glucose homoeostasis in men receiving chronic glucocorticoid therapy. Eur J Endocrinol 2013;168:243–51. doi:10.1530/EJE-12-0873 doi: 10.1530/EJE-12-0873
- Mähler A, Steiniger J, Endres M, Paul F, Boschmann M, Doss S. Increased catabolic state in spinocerebellar ataxia type 1 patients. Cerebellum 2014;13:440–6. doi:10.1007/s12311-014-0555-6 doi: 10.1007/s12311-014-0555-6
- Süssmuth SD, Müller VM, Geitner C, Landwehrmeyer GB, Iff S, Gemperli A, et al. Fat-free mass and its predictors in Huntington’s disease. J Neurol 2015;262:1533–40. doi:10.1007/s00415-015-7753-0 doi: 10.1007/s00415-015-7753-0